Clinical Trials Directory

Trials / Sponsors / Themis Bioscience GmbH

Themis Bioscience GmbH

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract
Gastrointestinal Cancer
Phase 12020-11-23
CompletedA Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)
Lassa Virus Infection
Phase 12019-09-26
CompletedSafety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)
Zika Virus Infection
Phase 12019-08-02
CompletedChikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)
Chikungunya Virus Infection
Phase 22019-07-16
CompletedSafety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005
Chikungunya Virus Infection
Phase 22018-08-22
CompletedStudy of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area
Chikungunya
Phase 22017-08-09
CompletedZika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)
Zika Virus
Phase 12017-05-03
CompletedPhase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine
Chikungunya Virus Infection
Phase 22016-08-17